Table 1 Demographic data for the cohort of participants with T2DM (n = 804)
Variable | Median [IQR] or n (%) |
|---|---|
Age (years) | 69 [65, 73] |
Female gender | 287 (35.7) |
Diabetes duration (years) | 10 [5, 17] |
Overweight and obese | 694 (86.4) |
Prior MI | 62 (7.7) |
Prior stroke | 48 (6) |
History of smoking (current & ex) | 386 (48) |
BMI | 29.3 [26.4, 33.2] |
WHR | 0.98 [0.92, 1.03] |
SBP (mmHg) | 131 [120, 142] |
DBP (mmHg) | 74 [67, 82] |
HbA1c (%) | 7.2 [6.5, 8.5] |
Creatinine (mmol/L) | 76 [65, 92] |
eGFR (ml/min/1.73m2) | 84.0 [70, 93] |
HDL (mg/dL) | 46 [39, 56] |
NTpBNP (pg/mL) | 50 [25, 101] |
hs-TnT (pg/mL) | 9.4 [6.8, 13.6] |
Medications | |
 Beta-blocker | 119 (14.8) |
 ACEi/ARB | 542 (67.4) |
 Diuretics | 159 (19.8) |
 CCB | 222 (27.6) |
 Statin | 552 (68.7) |
 Anti-platelet | 295 (36.7) |
 Insulin | 144 (18.0) |
 Metformin | 618 (77.1) |
Echocardiographic parameters | |
 GLS (%) | −18.0 [-19.3, −16.7] |
 E/e’ | 9.5 [7.8, 12] |
 E/A | 0.8 [0.68, 0.99] |
 e’(cm/s) | 7.0 [5.2, 8] |
 LAVi (ml/m2) | 32.7 [27.7, 39] |
 LVMi (g/m2) | 75.7 [64.1, 88.5] |
Risk scores | |
 ARIC-HF 4 year (%) | 8 [4, 12] |
 WATCH-DM (points) | 11 [9, 13] |